The estimated net worth of Mr. Fuad El-Hibri is at least $123,901,057 as of 10 Nov 2020. He owns shares worth
$10,251,557 as insider, has earned $90,849,500
from insider trading and has received compensation worth at least
$22,800,000 in Emergent BioSolutions Inc..
What is the salary of Fuad El-Hibri?
Mr. Fuad El-Hibri salary is $1,200,000 per year
as Founder & Executive Chairman in Emergent BioSolutions Inc..
How old is Fuad El-Hibri?
Mr. Fuad El-Hibri is 67 years old, born in 1958.
What stocks does Fuad El-Hibri currently own?
As insider, Mr. Fuad El-Hibri owns shares in one company:
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Mr. Fuad El-Hibri has made 146 insider trades between 2006-2020, according to the Form 4 filled with the SEC.
The largest trade he's
ever made was exercising 123,973 units of EBS stock
on 20 Jul 2010. As of 10 Nov 2020
he still owns at least 1,123,988 units of EBS stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Option
Stock Options (Right to Buy)
19,391
N/A
N/A
Sale
Common Stock
19,391
N/A
N/A
Option
Common Stock
19,391
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Option
Common Stock
20,000
N/A
N/A
Option
Stock Options (Right to Buy)
20,000
N/A
N/A
Option
Stock Options (Right to Buy)
20,000
N/A
N/A
Option
Common Stock
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Option
Common Stock
20,000
N/A
N/A
Option
Stock Options (Right to Buy)
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Sale
Common Stock
12,535
N/A
N/A
Sale
Common Stock
13,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Sale
Common Stock
20,000
$74.01
$1,480,200
Sale
Common Stock
20,000
$74.01
$1,480,200
Sale
Common Stock
20,000
$68.49
$1,369,800
Sale
Common Stock
20,000
$68.49
$1,369,800
Sale
Common Stock
20,000
$62.47
$1,249,400
Sale
Common Stock
12,537
$62.58
$784,565
Sale
Common Stock
6,261
$62.99
$394,380
Sale
Common Stock
17,071
$62.25
$1,062,670
Sale
Common Stock
23,716
$61.83
$1,466,360
Sale
Common Stock
37,362
$61.05
$2,280,763
Sale
Common Stock
14,336
$60.76
$871,055
Sale
Common Stock
28,240
$60.5
$1,708,520
Option
Common Stock
9,794
N/A
N/A
Sale
Common Stock
9,837
$56.97
$560,414
Option
Restricted Stock Unit
9,794
N/A
N/A
Option
Common Stock
6,429
N/A
N/A
Option
Restricted Stock Unit
6,429
N/A
N/A
Sale
Common Stock
13,619
$58.7
$799,435
Option
Restricted Stock Unit
6,010
N/A
N/A
Option
Common Stock
6,010
N/A
N/A
Option
Common Stock
18,567
$64.9
$1,204,998
Option
Employee Stock Options (Right to Buy)
18,567
$64.9
$1,204,998
Sale
Common Stock
18,567
$64.9
$1,204,998
Sale
Common Stock
4,751
$25.62
$121,721
Option
Employee Stock Options (Right to Buy)
4,751
$25.62
$121,721
Option
Common Stock
4,751
$25.62
$121,721
Option
Employee Stock Options (Right to Buy)
15,614
$63.9
$997,735
Sale
Common Stock
15,614
$63.9
$997,735
Option
Common Stock
15,614
$63.9
$997,735
Sale
Common Stock
4,386
$25.62
$112,369
Option
Employee Stock Options (Right to Buy)
4,386
$25.62
$112,369
Option
Common Stock
4,386
$25.62
$112,369
Option
Employee Stock Options (Right to Buy)
13,720
$62.9
$862,988
Sale
Common Stock
13,720
$62.9
$862,988
Option
Common Stock
13,720
$62.9
$862,988
Option
Employee Stock Options (Right to Buy)
6,280
$25.62
$160,894
Option
Common Stock
6,280
$25.62
$160,894
Sale
Common Stock
6,280
$25.62
$160,894
Option
Common Stock
11,684
$25.62
$299,344
Sale
Common Stock
11,684
$61.9
$723,240
Option
Employee Stock Options (Right to Buy)
11,684
$25.62
$299,344
Option
Common Stock
48,316
$25.62
$1,237,856
Sale
Common Stock
48,316
$60.66
$2,930,849
Option
Employee Stock Options (Right to Buy)
48,316
$25.62
$1,237,856
Option
Restricted Stock Units
9,722
N/A
N/A
Option
Common Stock
9,722
N/A
N/A
Sale
Common Stock
6,987
$58.47
$408,530
Sale
Common Stock
10,369
$58.24
$603,891
Option
Restricted Stock Units
9,794
N/A
N/A
Option
Common Stock
9,794
N/A
N/A
Sale
Common Stock
10,369
$58.24
$603,891
Option
Restricted Stock Units
6,430
$61.01
$392,294
Option
Common Stock
6,430
$61.01
$392,294
Option
Employee Stock Options (Right to Buy)
20,832
$69.59
$1,449,699
Sale
Common Stock
41,664
$69.59
$2,899,398
Option
Common Stock
20,832
$69.59
$1,449,699
Option
Common Stock
25,000
$13.38
$334,500
Option
Employee Stock Options (Right to Buy)
25,000
$13.38
$334,500
Sale
Common Stock
25,000
$69.96
$1,749,000
Option
Employee Stock Options (Right to Buy)
15,173
$14.44
$219,098
Sale
Common Stock
15,173
$70.03
$1,062,565
Option
Common Stock
15,173
$14.44
$219,098
Option
Employee Stock Options (Right to Buy)
20,000
$14.44
$288,800
Option
Common Stock
20,000
$14.44
$288,800
Sale
Common Stock
20,000
$69.54
$1,390,800
Sale
Common Stock
16,318
$56.57
$923,109
Sale
Common Stock
20,000
$55.5
$1,110,000
Sale
Common Stock
15,000
$54.51
$817,650
Sale
Common Stock
15,000
$53.61
$804,150
Option
Common Stock
13,237
N/A
N/A
Option
Restrictive Stock Units
13,237
N/A
N/A
Option
Restrictive Stock Units
9,723
N/A
N/A
Option
Common Stock
9,723
N/A
N/A
Option
Restrictive Stock Units
9,794
N/A
N/A
Option
Common Stock
9,794
N/A
N/A
Option
Common Stock
27,983
$42.08
$1,177,525
Option
Employee Stock Options (Right to Buy)
27,983
$42.08
$1,177,525
Sale
Common Stock
27,983
$42.08
$1,177,525
Option
Common Stock
20,000
$22.03
$440,600
Sale
Common Stock
20,000
$22.03
$440,600
Option
Employee Stock Options (Right to Buy)
20,000
$22.03
$440,600
Sale
Common Stock
40,000
$31.04
$1,241,600
Option
Common Stock
20,000
$22.03
$440,600
Option
Employee Stock Options (Right to Buy)
20,000
$22.03
$440,600
Sale
Common Stock
40,000
$31.04
$1,241,600
Option
Common Stock
20,000
$22.03
$440,600
Option
Employee Stock Options (Right to Buy)
20,000
$22.03
$440,600
Sale
Common Stock
25,000
$40.5
$1,012,500
Sale
Common Stock
25,000
$40.5
$1,012,500
Sale
Common Stock
23,547
$38.5
$906,560
Sale
Common Stock
1,453
$38.5
$55,941
Sale
Common Stock
16,439
$37.5
$616,463
Sale
Common Stock
3,100
$37.5
$116,250
Sale
Common Stock
5,461
$37.5
$204,788
Sale
Common Stock
25,000
$36.5
$912,500
Sale
Common Stock
25,000
$35.5
$887,500
Option
Restrictive Stock Units
20,554
N/A
N/A
Option
Common Stock
20,554
N/A
N/A
Option
Restrictive Stock Units
13,236
N/A
N/A
Option
Common Stock
13,236
N/A
N/A
Option
Restrictive Stock Units
9,722
N/A
N/A
Option
Common Stock
9,722
N/A
N/A
Sale
Common Stock
9,835
$43.5
$427,823
Option
Common Stock
24,594
$15.91
$391,291
Option
Employee Stock Option (right to buy)
24,594
$15.91
$391,291
Sale
Common Stock
39,759
$29.71
$1,181,041
Option
Common Stock
20,000
$15.91
$318,200
Sale
Common Stock
20,000
$15.91
$318,200
Option
EmployeeStock Option (right to buy)
20,000
$15.91
$318,200
Option
Common Stock
20,000
$15.91
$318,200
Option
EmployeeStock Option (right to buy)
20,000
$15.91
$318,200
Sale
Common Stock
20,000
$15.91
$318,200
Option
EmployeeStock Option (right to buy)
20,000
$15.91
$318,200
Option
Common Stock
20,000
$15.91
$318,200
Sale
Common Stock
45,000
$29.21
$1,314,225
Sale
Common Stock
25,000
$38.71
$967,750
Sale
Common Stock
4,209
$40.5
$170,465
Sale
Common Stock
20,791
$40.5
$842,036
Sale
Common Stock
50,000
$39.5
$1,975,000
Option
Restrictive Stock Units
6,967
N/A
N/A
Option
Common Stock
6,967
N/A
N/A
Option
Common Stock
18,746
N/A
N/A
Option
Restrictive Stock Units
18,746
N/A
N/A
Option
Restrictive Stock Units
12,073
N/A
N/A
Option
Common Stock
12,073
N/A
N/A
Option
Common Stock
27,900
$18.9
$527,310
Option
EmployeeStock Option
27,900
$18.9
$527,310
Sale
Common Stock
17,871
$37.5
$670,163
Sale
Common Stock
13,013
$36.5
$474,975
Option
Employee Stock Option
20,000
$18.9
$378,000
Option
Common Stock
20,000
$18.9
$378,000
Option
Employee Stock Option
20,000
$18.9
$378,000
Option
Common Stock
20,000
$18.9
$378,000
Sale
Common Stock
13,225
$35.5
$469,488
Option
Employee Stock Option
20,000
$18.9
$378,000
Sale
Common Stock
13,450
$34.5
$464,025
Option
Common Stock
20,000
$18.9
$378,000
Option
Common Stock
20,000
$18.9
$378,000
Sale
Common Stock
13,689
$33.5
$458,582
Option
Employee Stock Option
20,000
$18.9
$378,000
Sale
Common Stock
30,000
$35.5
$1,065,000
Sale
Common Stock
29,766
$34.5
$1,026,927
Sale
Common Stock
234
$34.5
$8,073
Sale
Common Stock
30,000
$33
$990,000
Sale
Common Stock
30,000
$33
$990,000
Sale
Common Stock
14,564
$32
$466,048
Sale
Common Stock
368
$32
$11,776
Sale
Common Stock
15,068
$32.03
$482,628
Sale
Common Stock
30,000
$32.26
$967,920
Option
Employee Stock Option (right to buy)
33,333
$7
$233,331
Option
Common Stock
33,333
$7
$233,331
Sale
Common Stock
15,325
$27.7
$424,472
Sale
Common Stock
68,413
$26
$1,778,738
Sale
Common Stock
416
$26
$10,816
Sale
Common Stock
50,512
$26
$1,313,312
Sale
Common Stock
14,355
$25
$358,875
Sale
Common Stock
1,490
$25
$37,250
Sale
Common Stock
2,126
$25
$53,150
Sale
Common Stock
6,888
$25
$172,200
Sale
Common Stock
2,311
$25
$57,775
Sale
Common Stock
1,633
$25
$40,825
Sale
Common Stock
70,796
$25
$1,769,900
Sale
Common Stock
62,851
$15.05
$945,593
Sale
Common Stock
52,021
$15.02
$781,355
Sale
Common Stock
43,064
$15.08
$649,534
Sale
Common Stock
22,875
$15.02
$343,583
Sale
Common Stock
34,061
$15.22
$518,238
Sale
Common Stock
77,900
$25.78
$2,008,340
Sale
Common Stock
31,336
$24.12
$755,887
Sale
Common Stock
16,438
$24.1
$396,139
Sale
Common Stock
2,226
$24.07
$53,571
Sale
Common Stock
33,185
$23.26
$771,717
Sale
Common Stock
23,815
$24.32
$579,181
Sale
Common Stock
12,500
$19
$237,500
Sale
Common Stock
6,300
$19
$119,700
Sale
Common Stock
6,127
$19
$116,413
Sale
Common Stock
123,973
$18.59
$2,304,286
Sale
Common Stock
9,000
$18
$162,000
Sale
Common Stock
75,433
$12.5
$942,913
Option
Employee Stock Option (right to buy)
33,333
$7
$233,331
Option
Common Stock
33,333
$7
$233,331
Option
Common Stock
27,000
$10.13
$273,510
Sale
Common Stock
52,000
$13.58
$706,160
Option
Employee Stock Option (right to buy)
27,000
$10.13
$273,510
Sale
Common Stock
23,300
$16.53
$385,196
Sale
Common Stock
1,700
$16.5
$28,050
Sale
Common Stock
900
$16
$14,400
Sale
Common Stock
4,200
$16.05
$67,389
Sale
Common Stock
13,400
$16.01
$214,507
Sale
Common Stock
6,500
$16.08
$104,533
Sale
Common Stock
12,000
$19
$228,000
Sale
Common Stock
45,400
$19.32
$877,128
Sale
Common Stock
16,500
$19.48
$321,420
Sale
Common Stock
11,100
$19.77
$219,447
Option
Common Stock
29,604
$7
$207,228
Sale
Common Stock
50,000
$19.84
$992,000
Option
Employee Stock Option (right to buy)
29,604
$7
$207,228
Option
Common Stock
74,000
$6.88
$508,898
Sale
Common Stock
74,000
$19.67
$1,455,580
Option
Employee Stock Option (right to buy)
90,270
$5.16
$465,613
Sale
Common Stock
37,700
$3.5
$131,950
Option
Common Stock
37,700
$3.5
$131,950
Option
Employee Stock Option (right to buy)
75,400
$1.75
$131,950
Option
Employee Stock Option (right to buy)
55,800
$9.68
$539,865
Option
Common Stock
27,900
$19.35
$539,865
Sale
Common Stock
27,900
$19.35
$539,865
Option
Employee Stock Option (right to buy)
95,200
$3.5
$333,200
Sale
Common Stock
47,600
$3.5
$166,600
Option
Common Stock
47,600
$3.5
$166,600
Sale
Common Stock
15,000
$16.67
$250,095
Sale
Common Stock
21,000
$15
$315,000
Sale
Common Stock
75,100
$15.02
$1,128,002
Sale
Common Stock
3,900
$15.09
$58,832
Sale
Common Stock
6,700
$14.02
$93,934
Sale
Common Stock
9,500
$14.02
$133,143
Sale
Common Stock
300
$14
$4,200
Sale
Common Stock
2,100
$14.11
$29,631
Sale
Common Stock
1,500
$14.02
$21,027
Sale
Common Stock
1,500
$14.03
$21,050
Sale
Common Stock
600
$14
$8,400
Sale
Common Stock
8,000
$14.1
$112,824
Sale
Common Stock
39,700
$14.21
$564,018
Sale
Common Stock
5,700
$14
$79,800
Sale
Common Stock
24,400
$14.04
$342,552
Sale
Common Stock
24,700
$13.03
$321,841
Sale
Common Stock
400
$13
$5,200
Sale
Common Stock
5,400
$13.04
$70,432
Sale
Common Stock
19,500
$13.03
$253,988
Sale
Common Stock
11,900
$12.57
$149,595
Sale
Common Stock
9,700
$12.58
$122,036
Sale
Common Stock
6,400
$12.56
$80,397
Sale
Common Stock
22,000
$12.55
$276,012
Option
Class B Common Stock
86,312
$3.5
$302,092
Option
Employee Stock Option (right to buy)
86,312
$3.5
$302,092
Emergent BioSolutions key executives
Emergent BioSolutions Inc. executives and other stock owners filed with the SEC:
Mr. Adam R. Havey(54)Executive Vice President & Chief Operating Officer
Mr. Atul Saran(52)Executive Vice President of Corporation Devel. & Ext. Affairs and Gen. Counsel
